The use of ultralow doses of antibodies to C-terminal fragment of angiotensin II AT1 receptor (kardos) in the therapy of arterial hypertension.
Bull Exp Biol Med
; 148(2): 332-4, 2009 Aug.
Article
em En
| MEDLINE
| ID: mdl-20027362
ABSTRACT
Kardos monotherapy allows attaining the target levels of systolic and diastolic blood pressure in patients with high-risk and very-high-risk hypertension. We demonstrated excellent tolerability of the preparation in combination with reliable blood pressure decrease over 24 h, during day and night hours.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Receptores de Angiotensina
/
Hipertensão
/
Anticorpos
/
Anti-Hipertensivos
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Bull Exp Biol Med
Ano de publicação:
2009
Tipo de documento:
Article